These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17368566)

  • 21. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.
    Cui Y; Niu M; Zhang X; Zhong Z; Wang J; Pang D
    Tumour Biol; 2015 Dec; 36(12):9919-27. PubMed ID: 26168958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the aggregation-prevention activity of p97/valosin-containing protein.
    Song C; Wang Q; Li CC
    Biochemistry; 2007 Dec; 46(51):14889-98. PubMed ID: 18044963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting valosin-containing protein suppresses osteosarcoma cell metastasis via AKT/nuclear factor of kappa B signaling pathway in vitro.
    Long XH; Zhang ZH; Liu ZL; Huang SH; Luo QF
    Indian J Pathol Microbiol; 2013; 56(3):190-5. PubMed ID: 24152492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valosin-containing protein from the hard tick Haemaphysalis longicornis: effects of dsRNA-mediated HlVCP gene silencing.
    Boldbaatar D; Battsetseg B; Hatta T; Miyoshi T; Tsuji N; Xuan X; Fujisaki K
    Biochem Cell Biol; 2007 Jun; 85(3):384-94. PubMed ID: 17612633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
    Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
    Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
    Sun M; Zhang J; Liu S; Liu Y; Zheng D
    Oncol Rep; 2008 Jan; 19(1):177-85. PubMed ID: 18097593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter.
    Liu R; Zhou A; Ren D; He A; Hu X; Zhang W; Yang L; Liu M; Li H; Zhou J; Xiang S; Zhang J
    FEBS J; 2009 Feb; 276(4):1114-24. PubMed ID: 19154347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the human CIDEA promoter in fat cells.
    Pettersson AT; Laurencikiene J; Nordström EA; Stenson BM; van Harmelen V; Murphy C; Dahlman I; Rydén M
    Int J Obes (Lond); 2008 Sep; 32(9):1380-7. PubMed ID: 18607384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
    Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
    Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
    Seyed M; Dimario JX
    J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein expression of the Ets transcription factor Elf-1 in breast cancer cells is negatively correlated with histological grading, but not with clinical outcome.
    Gerloff A; Dittmer A; Oerlecke I; Holzhausen HJ; Dittmer J
    Oncol Rep; 2011 Nov; 26(5):1121-5. PubMed ID: 21811762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
    Yamamoto S; Tomita Y; Hoshida Y; Sakon M; Kameyama M; Imaoka S; Sekimoto M; Nakamori S; Monden M; Aozasa K
    Clin Cancer Res; 2004 Jan; 10(2):651-7. PubMed ID: 14760088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological consequences of VCP mutations on human striated muscle.
    Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
    Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.